The effect of various medications on emotioal processing, attention, experiences and sensory information processing

INTERVENTION: Pharmaceutical Form: Tablet INN or Proposed INN: CITALOPRAM CAS Number: 59729‐33‐8 Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: ESCITALOPRAM Other descriptive name: ESCITALOPRAM Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: REBOXETINE Other descriptive name: REBOXETINE Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: MIRTAZAPINE Other descriptive name: MIRTAZAPINE Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: DULOXETINE CAS Number: 116539‐59‐4 Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: AGOMELATINE CAS Number: 138112‐76‐2 Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: SULPIRIDE CAS Number: 15676‐16‐1 Other descriptive name: SULPIRIDE Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: AMISULPRIDE CAS Number: 71675‐85‐9 Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: OXAZEPAM Other descriptive name: OXAZEPAM Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: HALOPERIDOL CAS Number: 52‐86‐8 Other descriptive name: HALOPERIDOL Pharmaceutical form of the placebo: Capsule Route of administration of the placebo: Oral use Pharmaceutical Form: Tablet INN or Proposed INN: FAMOTIDINE Other descriptive name: FAMOTIDINE Pharmaceutica CONDITION: Healthy volunteers Therapeutic area: Psychiatry and Psychology [F] ‐ Psychological processes [F02] PRIMARY OUTCOME: Main Objective: To study the effect of various medications on emotioal processing, attention, experiences and sensory information processing Primary end point(s): Change in emotioal processing, attention, experiences and sensory information processing. Secondary Objective: Not applicable Timepoint(s) of evaluation of this end point: 2 hours to 7 days after administration. INCLUSION CRITERIA: Healthy volunteers Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range 150 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range